LARGE CELL LUNG CANCER

LARGE CELL LUNG CANCER was reported 23 times

LARGE CELL LUNG CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] 1 0.0001
1 Non-narcotic Antitussive [EPC] 1 0.0001
2 PCSK9 Inhibitor [EPC] 1 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Androgen Receptor Inhibitor [EPC] 2 0.0000
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
7 Pyridone [EPC] 1 0.0000
8 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
9 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
10 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
11 Nitroimidazole Antimicrobial [EPC] 1 0.0000
12 Tetracycline-class Drug [EPC] 1 0.0000
13 Topoisomerase Inhibitor [EPC] 1 0.0000
14 Nitrate Vasodilator [EPC] 1 0.0000
15 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
16 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
17 Proton Pump Inhibitor [EPC] 5 0.0000
18 Fluoroquinolone Antibacterial [EPC] 1 0.0000
19 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
20 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
21 Aldosterone Antagonist [EPC] 1 0.0000
22 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
23 Endothelin Receptor Antagonist [EPC] 1 0.0000
24 Expectorant [EPC] 1 0.0000
25 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
26 Retinoid [EPC] 1 0.0000
27 Loop Diuretic [EPC] 1 0.0000
28 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
29 Kinase Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
32 Corticosteroid [EPC] 1 0.0000